SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by DIACOUSTIC MEDICAL DEVICES (PTY)
VS
by Powerful Medical

AI Verdict

These tools are adjacent in their utility for cardiac diagnostics, both falling under Cardiology AI and Clinical Decision Support. SensiCardiac Mobi focuses on analyzing acoustic heart signals from stethoscopes to diagnose heart murmurs, while PMcardio interprets ECGs to assess a broader range of over 50 cardiac conditions. A physician would choose SensiCardiac Mobi for murmur-specific analysis and PMcardio for comprehensive ECG interpretation.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if your primary need is to accurately differentiate between physiological and pathological heart murmurs using acoustic heart signals. This tool is ideal for physicians in a clinical setting who require AI-powered decision support to analyze heart sounds recorded with an electronic stethoscope, aiding in the identification of S1, S2, and suspected murmurs.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose PMcardio if…

Choose PMcardio if you need rapid and accurate interpretation of 12-lead ECGs for the assessment of a wide range of cardiac conditions, including critical events like STEMI and OMI. This platform is best suited for healthcare professionals across various specialties, including emergency medicine and cardiology, who require instant, expert-level ECG analysis, AI explainability, and integration with EHR/CVIS systems for enhanced cardiac care coordination.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION PMcardio
Pricing Contact for pricing Freemium
Deployment Hosted server environment (Linux OS) with a mobile application interface Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
BAA Available Yes AI-estimated Unknown
FDA Status 1 AI-estimated Pending AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app for both iOS and Android, a web platform, and enterprise integrations, providing more flexible access points for users. SensiCardiac Mobi is primarily a mobile application for iOS, requiring a specific electronic stethoscope, which could limit its usability for some practitioners. Additionally, PMcardio offers a free plan, allowing users to experience the application before committing to a paid subscription, which enhances its accessibility and user-friendliness.

Clinical Value

PMcardio

PMcardio is clinically validated in over 25 studies and detects more than 50 cardiac conditions from ECGs, including STEMI/OMI, rhythms, and reduced LVEF. SensiCardiac Mobi focuses on differentiating physiological and pathological heart murmurs using acoustic signals, which is a narrower scope. While SensiCardiac Mobi is FDA-cleared, PMcardio's extensive validation and broader diagnostic capabilities suggest higher clinical value across a wider range of cardiac conditions.

Pricing & Value

PMcardio

PMcardio offers a transparent freemium model with a free plan for limited use and tiered pricing for individuals, teams, and organizations, providing flexibility and clear cost expectations. SensiCardiac Mobi's pricing is not publicly available and requires direct contact for details, which can be a barrier to assessing its value proposition. PMcardio's free tier allows users to evaluate its utility before investment, offering better perceived value.

Enterprise Readiness

PMcardio

PMcardio is designed for enterprise deployment with integrations into EHR/CVIS and EMS systems, offering features like governance, role-based access, and workflow alignment for multi-pathway, multi-site cardiac care. SensiCardiac Mobi's deployment is described as a hosted server environment with a mobile application, but specific enterprise integration features and scalability for large health systems are not detailed.

Innovation

PMcardio

PMcardio demonstrates greater innovation with features like 'Queen of Hearts' for STEMI/OMI detection, 'LVsense' for reduced LVEF detection, and 'ECGxplain' for visual AI explainability using heatmaps. SensiCardiac Mobi's innovation lies in its AI-powered heart murmur differentiation, but PMcardio's broader range of AI-driven diagnostic tools and explainable AI features suggest a more advanced and innovative approach to cardiac care.

Support & Docs

PMcardio

PMcardio provides a comprehensive Help Center, FAQs, and regulatory documentation, including instructions for use in multiple languages, indicating robust support resources. SensiCardiac Mobi's documentation mentions a user manual and FDA 510(k) summary, but a broader range of accessible support resources like those offered by PMcardio is not explicitly detailed.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION PMcardio
Tool Name SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION PMcardio
Company DIACOUSTIC MEDICAL DEVICES (PTY) Powerful Medical
Description SensiCardiac Mobi is an FDA-cleared AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds. PMcardio is a CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians, it delivers rapid, expert-level interpretations, empowering various healthcare professionals to act with confidence at the point of care.
Categories Cardiology AI, Clinical Decision Support & Reference Cardiology AI, Clinical Decision Support & Reference
Specialties Cardiology, Internal Medicine, Pediatrics Cardiology, Emergency Medicine, Internal Medicine
Key Functionality Analyzes acoustic heart signals to differentiate between physiological and pathological heart murmurs, identifies S1, S2, and suspected murmurs, records heart sounds at four main auscultation positions. Interprets ECGs to assess over 50 cardiac conditions, including STEMI/OMI, rhythms, reduced LVEF, conduction disorders, provides visual AI explainability with heatmaps, automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals.

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

SensiCardiac Mobi is a mobile application that acquires and records heart sounds using a compatible electronic stethoscope, operating as decision support software. PMcardio for Organizations offers enterprise integrations with EHR/CVIS and EMS systems, aiming for seamless workflow integration, real-time alerts, and care routing.
SensiCardiac Mobi assists in diagnosing heart murmurs by differentiating between physiological and pathological sounds, identifying S1, S2, and suspected murmurs. PMcardio has demonstrated high accuracy in interpreting ECGs, with a sensitivity of 86% and specificity of 92% for major ECG abnormalities, and 97% sensitivity and 99% specificity for Atrial Fibrillation.
SensiCardiac Mobi is primarily for Cardiology, Internal Medicine, and Pediatrics, focusing on heart murmur diagnosis during physical examinations, sports physicals, and routine check-ups. PMcardio is suitable for Cardiology, Emergency Medicine, and Internal Medicine, offering broad coverage for over 50 cardiac conditions from ECGs, including STEMI/OMI detection, reduced LVEF, and various arrhythmias, and provides treatment recommendations based on ESC guidelines.
SensiCardiac Mobi's user interface was adapted for mobile devices, with user testing indicating high usability. PMcardio aims to ease the learning curve with a brief guide for digitizing ECGs, emphasizing two simple rules for correct digitization: matching the ECG pictogram to the recording layout and ensuring horizontal positioning of leads.
PMcardio is trusted by over 100,000 clinicians and deployed in over 150 hospitals worldwide, with testimonials and case studies highlighting its impact on reducing false cath lab activations and improving STEMI detection. Information regarding customer references for SensiCardiac Mobi is not explicitly detailed in the provided data.
PMcardio for Organizations includes full audit trails for every pathway action, along with governance and role-based access control. Specific audit-trail features for SensiCardiac Mobi are not detailed in the provided information.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.